Analysis of clinical application effects of cefminox in infected patients
Objective To analyze the value of clinical application of cefminox in the treatment of infection.Methods A total of 92 infected patients were divided into a control group and an experimental group by coin tossing method,each consisting of 46 patients.The control group received routine treatment,while the experimental group received cefminox for injection treatment.The inflammatory markers(C-reactive protein,interleukin-6,tumor necrosis factor-α),clinical efficacy,occurrence of adverse reactions and satisfaction rate were compared between the two groups.Results Before treatment,the levels of C-reactive protein,interleukin-6 and tumor necrosis factor-α were not different among the three groups(P＞0.05).After treatment,the levels of C-reactive protein,interleukin-6 and tumor necrosis factor-α in both groups were lower than those before treatment;the experimental group had C-reactive protein of(5.81±1.09)mg/L,interleukin-6 of(42.97±5.01)pg/ml,and tumor necrosis factor-α of(51.96±8.29)pg/ml,which were lower than(7.42±1.23)mg/L,(54.06±8.47)pg/ml,and(67.31±9.95)pg/ml in the control group(P＜0.05).The total clinical effective rate of 97.83% in the experimental group was higher than 82.61% in the control group(P＜0.05).The incidence of adverse reactions of 2.17% in the experimental group was lower than 15.22% in comparison group(P＜0.05).The total satisfaction rate of 95.65% in the experimental group was higher than 80.43% in the control group(P＜0.05).Conclusion Cefminox has good curative effect on infected patients,and can prevent and control adverse reactions,strengthens anti-inflammatory mechanisms,which may accelerate recovery from inflammatory lesions and enhance patient satisfaction.
NETL
NSTL
万方数据
